tiprankstipranks
Trevi Therapeutics Inc (TRVI)
NASDAQ:TRVI
US Market

Trevi Therapeutics (TRVI) Similar Stocks

Compare
457 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Trevi Therapeutics
$6.40
$618.77M
94.99%
10 Buy
0 Hold
0 Sell
Strong Buy
Cytokinetics
$44.55
$5.38B
-33.86%
15 Buy
1 Hold
0 Sell
Strong Buy
Neurocrine
$116.18
$11.16B
35.13
-17.70%
17 Buy
5 Hold
0 Sell
Strong Buy
SAGE Therapeutics
$8.53
$498.00M
-54.19%
2 Buy
14 Hold
1 Sell
Hold
Xenon
$36.45
$2.71B
-18.27%
11 Buy
0 Hold
0 Sell
Strong Buy
Axsome Therapeutics
$120.36
$6.18B
56.88%
17 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
TRVI
Trevi Therapeutics
6.61
3.22
94.99%
CYTK
Cytokinetics
44.55
-26.60
-37.39%
NBIX
Neurocrine
116.18
-24.98
-17.70%
SAGE
SAGE Therapeutics
8.53
-10.09
-54.19%
XENE
Xenon
34.90
-7.76
-18.19%
AXSM
Axsome Therapeutics
120.36
43.64
56.88%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis